PTCT: PTC Therapeutics Inc
PTCT exchange rate has changed by 0.47% for today. During the day, the instrument was traded at a low of 69.92 and at a high of 72.97.
Follow PTC Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
PTCT News
- Leqembi Isn’t Enough To Save Biogen Momentum (NASDAQ:BIIB)
- KROS Turns to Next Wave of TGF-Beta Muscle Therapies
- KROS Turns to Next Wave of TGF-Beta Muscle Therapies
- Should You Buy KROS After Q1 Miss and Takeda Deal Reset?
- Should You Buy KROS After Q1 Miss and Takeda Deal Reset?
- KROS Stock Guide to Rinvatercept in DMD and ALS for 2026
- KROS Stock Guide to Rinvatercept in DMD and ALS for 2026
- PTC Therapeutics: Sephience Turns The Story From Regulatory Repair To Operating Leverage
- Compared to Estimates, PTC Therapeutics (PTCT) Q1 Earnings: A Look at Key Metrics
- PTC Therapeutics (PTCT) Reports Q1 Loss, Tops Revenue Estimates
- Exploring Analyst Estimates for PTC Therapeutics (PTCT) Q1 Earnings, Beyond Revenue and EPS
- Agenus (AGEN) Earnings Expected to Grow: What to Know Ahead of Q1 Release
- PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
- KROS 2026 Watchlist: 3 Catalysts That Could Reset Sentiment
- KROS Stock: Does the Takeda Deal Lower Dilution Risk in 2026?
- KROS Rinvatercept: What to Know Before DMD Phase II Starts
- KROS Pipeline Catalysts: DMD Phase II and ALS Plans for 2026
- KROS Stock: What to Know About Rinvatercept in DMD
- KROS: Is the Discount Book Value a Value Trap?
- PTC Therapeutics, Inc. (PTCT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
- PTC Therapeutics at Leerink Conference: Strategic Growth in PKU Market
- PTC Therapeutics, Inc. (PTCT) Presents at Leerink Global Healthcare Conference 2026 Transcript
- Can Keros Therapeutics Rinvatercept Stand Out in the DMD Market?
Frequently Asked Questions
What is PTCT stock price today?
PTC Therapeutics Inc stock is priced at 70.97 today. It trades within 69.92 - 72.97, yesterday's close was 70.64, and trading volume reached 1726. The live price chart of PTCT shows these updates.
Does PTC Therapeutics Inc stock pay dividends?
PTC Therapeutics Inc is currently valued at 70.97. Dividend policy depends on the company, while investors also watch 45.61% and USD. View the chart live to track PTCT movements.
How to buy PTCT stock?
You can buy PTC Therapeutics Inc shares at the current price of 70.97. Orders are usually placed near 70.97 or 71.27, while 1726 and 0.27% show market activity. Follow PTCT updates on the live chart today.
How to invest into PTCT stock?
Investing in PTC Therapeutics Inc involves considering the yearly range 44.17 - 87.50 and current price 70.97. Many compare -3.15% and -7.05% before placing orders at 70.97 or 71.27. Explore the PTCT price chart live with daily changes.
What are PTC Therapeutics Inc stock highest prices?
The highest price of PTC Therapeutics Inc in the past year was 87.50. Within 44.17 - 87.50, the stock fluctuated notably, and comparing with 70.64 helps spot resistance levels. Track PTC Therapeutics Inc performance using the live chart.
What are PTC Therapeutics Inc stock lowest prices?
The lowest price of PTC Therapeutics Inc (PTCT) over the year was 44.17. Comparing it with the current 70.97 and 44.17 - 87.50 shows potential long-term entry points. Watch PTCT moves on the chart live for more details.
When did PTCT stock split?
PTC Therapeutics Inc has gone through stock splits historically. These changes are visible in , 70.64, and 45.61% after corporate actions.
- Previous Close
- 70.64
- Open
- 70.78
- Bid
- 70.97
- Ask
- 71.27
- Low
- 69.92
- High
- 72.97
- Volume
- 1.726 K
- Daily Change
- 0.47%
- Month Change
- -3.15%
- 6 Months Change
- -7.05%
- Year Change
- 45.61%
- Act
- Fcst
- Prev